Venetoclax in Combination with Daratumumab for Multiple Myeloma Treatment

Sponsored in Part by AbbVie/Content Independently Developed by Targeted Oncology. A look at clinical trial efficacy data on daratumumab plus bortezomib and venetoclax for multiple myeloma treatment.

Related Videos
Hans Hammers, MD, PhD, an expert on renal cell carcinoma
Natalie Callander, MD, an expert on multiple myeloma
Natalie Callander, MD, an expert on multiple myeloma
Natalie Callander, MD, an expert on multiple myeloma
Natalie Callander, MD, an expert on multiple myeloma
Natalie Callander, MD, an expert on multiple myeloma
Natalie Callander, MD, an expert on multiple myeloma
Natalie Callander, MD, an expert on multiple myeloma
Related Content